|
Real-time Estimate
Tradegate
14:05:15 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 386.40 EUR | -0.62% |
|
+3.96% | +6.93% |
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.45% | +2.67% | -6.55% | +4.27% | +6.58% | +50.14% | +100.50% | +394.49% | +1,346.99% | 1,027B | |
| +0.30% | +1.90% | -0.18% | +18.50% | +30.77% | +55.39% | +66.58% | +65.21% | +130.01% | 651B | |
| +0.31% | +2.81% | +2.09% | +22.10% | +15.69% | +19.08% | +71.72% | +148.44% | +320.19% | 467B | |
| -1.22% | +3.66% | -1.14% | +11.85% | +8.71% | +36.44% | +38.32% | +4.48% | +47.13% | 350B | |
| -0.79% | +2.73% | -8.33% | -2.49% | +5.02% | +19.03% | +25.08% | +49.07% | +46.44% | 268B | |
| +0.58% | +6.76% | +5.88% | -4.97% | -9.35% | +11.13% | +16.52% | +46.05% | +146.11% | 257B | |
| +0.99% | +1.44% | -9.99% | +13.39% | +16.95% | +38.78% | +45.47% | +77.95% | +123.36% | 205B | |
| +0.79% | +1.84% | -4.99% | +0.52% | -13.44% | -28.27% | -56.71% | -11.24% | +82.35% | 190B | |
| +0.19% | +4.94% | +5.15% | +21.87% | +22.88% | +32.75% | +99.45% | +112.55% | +90.94% | 187B | |
| -0.38% | -0.74% | +0.97% | +9.14% | +10.50% | +13.93% | -18.21% | -37.75% | -18.23% | 158B | |
| -1.61% | -1.76% | -4.13% | +12.12% | +11.69% | +30.81% | +43.86% | +172.73% | +454.88% | 131B | |
| -0.28% | -1.60% | -5.19% | +15.96% | +16.09% | +37.32% | +6.90% | +3.50% | +13.69% | 128B | |
| -1.61% | +1.08% | -4.66% | +0.97% | -10.48% | -7.61% | -27.17% | -9.71% | +6.35% | 104B | |
| -1.18% | +6.04% | -0.56% | -2.37% | +2.90% | +27.46% | +24.72% | +6.98% | -8.72% | 102B | |
| +0.93% | +5.11% | -1.72% | -11.82% | -18.16% | +0.36% | +49.02% | +60.73% | +479.89% | 70.58B | |
| +0.37% | +5.50% | +8.25% | +20.86% | +23.43% | +34.72% | +22.80% | +56.52% | +29.82% | 60.94B | |
| -1.94% | -0.17% | -1.33% | +29.45% | +29.94% | +74.56% | -1.14% | +6.23% | -47.50% | 55.31B | |
| -0.41% | +0.85% | +0.85% | +18.33% | +36.49% | +95.25% | +283.60% | +334.86% | -23.52% | 45.67B | |
| +1.57% | +2.28% | -16.95% | -6.55% | -26.29% | -37.39% | +0.71% | -6.47% | +177.34% | 42.47B | |
| Average | -0.27% | +2.23% | -2.24% | +9.01% | +8.42% | +26.52% | +41.68% | +77.61% | +178.82% | 236.79B | |
| Weighted average by Cap. | -0.19% | +2.44% | -2.44% | +9.66% | +10.70% | +32.89% | +53.98% | +137.44% | +408.96% |
- Stock Market
- Stocks
- ROP Stock
- RHO Stock
- Sector Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
